Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003095
Filing Date
2025-04-07
Accepted
2025-04-07 21:41:34
Documents
1
Period of Report
2025-04-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4299
  Complete submission text file 0001641172-25-003095.txt   5814
Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address
Cunningham, Richard Anthony (Reporting) CIK: 0001624783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 25820001

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)